Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer

Keywords

Preimplantation genetic diagnosis, Genetic counseling, Genetic testing, Breast cancer, Medicine

References

• Prenatal diagnosis of Down syndrome: Ten year experience in the Israeli populationMordechai Shohat, Helena Frimer, Vered Shohat‐Levy — 2003
• Decisions About Testing and Termination of Pregnancy for Different Fetal Conditions: A Qualitative Study of European White and Pakistani Mothers of Affected ChildrenShenaz Ahmed, Jenny Hewison, Josephine M. Green — 2008
• Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic.Eyal Sheiner, Ilana Shoham‐Vardi, Dalia Weitzman — 1998
• Identification of the breast cancer susceptibility gene BRCA2Richard Wooster, Graham R. Bignell, Jonathan Lancaster — 1995
• Attitudes of high-risk women toward preimplantation genetic diagnosis.Gwendolyn P. Quinn, Susan T. Vadaparampil, Crystal Wilson — 2009
• Evaluating Online Direct-to-Consumer Marketing of Genetic Tests: Informed Choices or Buyers Beware?Rose Geransar, Edna Einsiedel — 2008
• Characteristics of women who refuse an offer of prenatal diagnosis: data from the California maternal serum alpha fetoprotein blood test experience.Nancy Press, Carole H. Browner — 1998
• Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics.Susannah Baruch, David Kaufman, Kathy Hudson — 2008
• Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriersAshley D. Staton, Allison W. Kurian, Kristin Cobb — 2007
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Mary‐Claire King, Joan H. Marks, Jessica B. Mandell — 2003
• Cancer genetic testing and assisted reproduction.Kenneth Offit, Kelly Kohut, Bartholt Clagett — 2006
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.Marcia S. Brose — 2002
• Fertility intentions following testing for a BRCA1 gene mutation.Ken R. Smith, Lee Ellington, Anna Chan — 2004
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Yoshio Miki, Jeffrey Swensen, Donna Shattuck-Eidens — 1994
• Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.Usha Menon, Joyce Harper, Anju Sharma — 2007
• Prenatal diagnosis and genetic screening--integration into prenatal care.Valerie J. Rappaport — 2008
• A Mechanism for Cox-2 Inhibitor Anti-Inflammatory Activity in Chemoprevention of Epithelial CancersElizabeth R. Smith, Mary B. Daly, Xiang‐Xi Xu — 2004
• Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.D. Fortuny, Judith Balmañà, Begoña Graña — 2008
• Preimplantation genetic diagnosis for BRCA1/2—a novel clinical experienceM. Sagi, N. Weinberg, Avital Eilat — 2009
• Preimplantation Genetic Diagnosis—An OverviewCaroline Mackie Ogilvie, Peter Braude, Paul N. Scriven — 2005

Cited by

• BRCA carriers' thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: when too many choices are just as difficult as none.Gwendolyn P. Quinn, Susan T. Vadaparampil, Sharon Tollin — 2010
• Knowledge, attitudes, and clinical experience of physicians regarding preimplantation genetic diagnosis for hereditary cancer predisposition syndromesAmanda Brandt, Matthew L. Tschirgi, Kaylene Ready — 2010
• Hereditary breast cancer and genetic counseling in young womenJoan Brunet — 2010
• 100 years lynch syndrome: what have we learned about psychosocial issues?Eveline M. A. Bleiker, Mary Jane Esplen, Bettina Meiser — 2013
• Comparison of Attitudes Regarding Preimplantation Genetic Diagnosis Among Patients with Hereditary Cancer SyndromesThereasa A. Rich, Mei Liu, Carol J. Etzel — 2013
• High-risk consumers’ perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysisGwendolyn P. Quinn, Tuya Pal, Devin Murphy — 2011
• ‘My funky genetics’: BRCA1/2 mutation carriers’ understanding of genetic inheritance and reproductive merger in the context of new repro-genetic technologiesAllison Werner‐Lin, Lisa R. Rubin, Maya Doyle — 2012
• BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosisClaire Julian‐Reynier, Roxane Fabre, Isabelle Coupier — 2012
• Genetic/familial high-risk assessment: breast and ovarian.Mary B. Daly, Jennifer E. Axilbund, Saundra S. Buys — 2010
• Expanding indications for preimplantation genetic diagnosisAnver Kuliev — 2011
• High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer.Gwendolyn P. Quinn, Susan T. Vadaparampil, Cheryl A. Miree — 2010
• Essential Genetic and Genomic Nursing Competencies for the Oncology NurseJean Jenkins — 2011
• Reproductive Endocrinologists’ Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation CarriersAllison L. Goetsch, Catherine Wicklund, Marla L. Clayman — 2015
• “I Do Not Want My Baby to Suffer as I Did”; Prenatal and Preimplantation Genetic Diagnosis for BRCA1/2 Mutations: A Case Report and Genetic Counseling ConsiderationsEfrat Dagan, Ruth Gershoni‐Baruch, Alina Kurolap — 2014
• Waiting for Cancer to Come: Women’s Experiences with Genetic Testing and Medical Decision Making for Breast and Ovarian CancerS. Hesse-Biber — 2014
• REPRODUCTIVE DECISION-MAKING IN WOMEN WITH BRCA1/2 MUTATIONSJessica L. Chan, Lauren Johnson, Mary D. Sammel — 2016
• Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partnersJoyce J. G. Gietel‐Habets, Christine de Die‐Smulders, I. A. P. Derks-Smeets — 2017
• “It was an Emotional Baby”: Previvors’ Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer RiskMarleah Dean, Emily A. Rauscher — 2017
• Performing and Declining PGD: Accounts of Jewish Israeli Women Who Carry a BRCA1/2 Mutation or Partners of Male Mutation CarriersEfrat Dagan, Daphna Birenbaum‐Carmeli, Eitan Friedman — 2017
• How Can Contingent Valuation Inform the Bioethics Debate? Evidence from a Survey on Hereditary Cancers in FranceChristel Protière, Olivier Chanel, Catherine Noguès — 2017

Related papers

• Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic TestingKarin Wagner, Haikady N. Nagaraja, Dawn C. Allain — 2017
• Perception of genetic testing among patients with inherited retinal disease: Benefits and challenges in a Japanese populationAkira Inaba, Akiko Yoshida, Akiko Maeda — 2022
• Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case StudyMaegan E. Roberts, Douglas L. Riegert‐Johnson, Brittany C. Thomas — 2011
• Uptake of genetic testing among patients seeking cancer genetic counseling in TaiwanSu‐Ying Fang, Ling‐Ling Hsieh, Chen‐Fang Hung — 2023
• Attitudes and Practices Among Internists Concerning Genetic TestingRobert Klitzman, Wendy K. Chung, Karen Marder — 2012
• A Commentary on Commercial Genetic Testing and the Future of the Genetic Counseling ProfessionNicholas D. Wolff, Jon A. Wolff — 2018
• Patients' attitudes regarding genetic counseling before germline BRCA1/2 pathogenic variants testing in Taiwan: A single‐country, multi‐center, patient‐reported outcome studyWen‐Ling Kuo, Po‐Han Lin, Meng‐Ting Peng — 2023
• Elective genomic testing: Practice resource of the National Society of Genetic CounselorsCarrie L. Blout Zawatsky, David Bick, Louise Bier — 2023
• OP009: Feasibility of a traceback approach to facilitate genetic testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) studyHeather Spencer Feigelson, Yolanda Prado, Tia L. Kauffman — 2022
• Genetic risk assessment, counseling and testing.Thereasa A. Rich, Mary K. Salazar — 2009